THALES SA (CSF.DE) Stock Fundamental Analysis
Europe - FRA:CSF - FR0000121329 - Common Stock
242.4 EUR
+4.2 (+1.76%)
Overall CSF gets a fundamental rating of 5 out of 10. We evaluated CSF against 46 industry peers in the Aerospace & Defense industry. There are concerns on the financial health of CSF while its profitability can be described as average. CSF has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
CSF had positive earnings in the past year.
In the past year CSF had a positive cash flow from operations.
In the past 5 years CSF has always been profitable.
CSF had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CSF has a worse Return On Assets (2.74%) than 63.04% of its industry peers.
The Return On Equity of CSF (14.93%) is comparable to the rest of the industry.
The Return On Invested Capital of CSF (11.65%) is better than 76.09% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CSF is in line with the industry average of 9.34%.
The 3 year average ROIC (8.24%) for CSF is below the current ROIC(11.65%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.74% | ||
| ROE | 14.93% | ||
| ROIC | 11.65% |
ROA(3y)3.15%
ROA(5y)2.86%
ROE(3y)16.5%
ROE(5y)15.14%
ROIC(3y)8.24%
ROIC(5y)7.14%
1.3 Margins
Looking at the Profit Margin, with a value of 4.99%, CSF is in line with its industry, outperforming 43.48% of the companies in the same industry.
CSF's Profit Margin has improved in the last couple of years.
CSF has a Operating Margin (9.24%) which is comparable to the rest of the industry.
CSF's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 26.11%, CSF is in line with its industry, outperforming 43.48% of the companies in the same industry.
In the last couple of years the Gross Margin of CSF has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.24% | ||
| PM (TTM) | 4.99% | ||
| GM | 26.11% |
OM growth 3Y5%
OM growth 5Y2.94%
PM growth 3Y0.86%
PM growth 5Y2.5%
GM growth 3Y1.59%
GM growth 5Y1.22%
2. Health
2.1 Basic Checks
CSF has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CSF has been reduced compared to 1 year ago.
CSF has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CSF has been reduced compared to a year ago.
2.2 Solvency
CSF has an Altman-Z score of 1.67. This is a bad value and indicates that CSF is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.67, CSF is not doing good in the industry: 73.91% of the companies in the same industry are doing better.
The Debt to FCF ratio of CSF is 3.07, which is a good value as it means it would take CSF, 3.07 years of fcf income to pay off all of its debts.
CSF's Debt to FCF ratio of 3.07 is fine compared to the rest of the industry. CSF outperforms 73.91% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that CSF is somewhat dependend on debt financing.
CSF has a Debt to Equity ratio (0.56) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 3.07 | ||
| Altman-Z | 1.67 |
ROIC/WACC1.53
WACC7.62%
2.3 Liquidity
A Current Ratio of 0.82 indicates that CSF may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.82, CSF is doing worse than 93.48% of the companies in the same industry.
CSF has a Quick Ratio of 0.82. This is a bad value and indicates that CSF is not financially healthy enough and could expect problems in meeting its short term obligations.
CSF has a Quick ratio of 0.61. This is in the lower half of the industry: CSF underperforms 69.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.61 |
3. Growth
3.1 Past
CSF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.91%.
CSF shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.55% yearly.
The Revenue has grown by 11.16% in the past year. This is quite good.
CSF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.26% yearly.
EPS 1Y (TTM)-22.91%
EPS 3Y10.55%
EPS 5Y5.55%
EPS Q2Q%-34.49%
Revenue 1Y (TTM)11.16%
Revenue growth 3Y8.32%
Revenue growth 5Y2.26%
Sales Q2Q%8.14%
3.2 Future
Based on estimates for the next years, CSF will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.81% on average per year.
Based on estimates for the next years, CSF will show a quite strong growth in Revenue. The Revenue will grow by 9.10% on average per year.
EPS Next Y10.26%
EPS Next 2Y13.58%
EPS Next 3Y13.1%
EPS Next 5Y12.81%
Revenue Next Year9.05%
Revenue Next 2Y8.21%
Revenue Next 3Y8.12%
Revenue Next 5Y9.1%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 46.89, the valuation of CSF can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CSF is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.28. CSF is valued rather expensively when compared to this.
CSF is valuated rather expensively with a Price/Forward Earnings ratio of 21.33.
76.09% of the companies in the same industry are more expensive than CSF, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CSF to the average of the S&P500 Index (33.61), we can say CSF is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.89 | ||
| Fwd PE | 21.33 |
4.2 Price Multiples
65.22% of the companies in the same industry are more expensive than CSF, based on the Enterprise Value to EBITDA ratio.
76.09% of the companies in the same industry are more expensive than CSF, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.97 | ||
| EV/EBITDA | 17.12 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CSF does not grow enough to justify the current Price/Earnings ratio.
CSF has a very decent profitability rating, which may justify a higher PE ratio.
CSF's earnings are expected to grow with 13.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.57
PEG (5Y)8.45
EPS Next 2Y13.58%
EPS Next 3Y13.1%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.59%, CSF has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.14, CSF pays a better dividend. On top of this CSF pays more dividend than 84.78% of the companies listed in the same industry.
Compared to the average S&P500 Dividend Yield of 2.36, CSF is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.59% |
5.2 History
The dividend of CSF is nicely growing with an annual growth rate of 9.56%!
Dividend Growth(5Y)9.56%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
CSF pays out 71.25% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CSF is growing, but earnings are growing more, so the dividend growth is sustainable.
DP71.25%
EPS Next 2Y13.58%
EPS Next 3Y13.1%
FRA:CSF (11/10/2025, 7:00:00 PM)
242.4
+4.2 (+1.76%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners22.57%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap49.92B
Revenue(TTM)21.35B
Net Income(TTM)1.07B
Analysts77.78
Price Target282.24 (16.44%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.59% |
Yearly Dividend3.44
Dividend Growth(5Y)9.56%
DP71.25%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.41%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.26%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.89 | ||
| Fwd PE | 21.33 | ||
| P/S | 2.34 | ||
| P/FCF | 20.97 | ||
| P/OCF | 16.4 | ||
| P/B | 6.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.12 |
EPS(TTM)5.17
EY2.13%
EPS(NY)11.36
Fwd EY4.69%
FCF(TTM)11.56
FCFY4.77%
OCF(TTM)14.78
OCFY6.1%
SpS103.67
BVpS34.66
TBVpS-17.3
PEG (NY)4.57
PEG (5Y)8.45
Graham Number63.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.74% | ||
| ROE | 14.93% | ||
| ROCE | 14.78% | ||
| ROIC | 11.65% | ||
| ROICexc | 16.44% | ||
| ROICexgc | N/A | ||
| OM | 9.24% | ||
| PM (TTM) | 4.99% | ||
| GM | 26.11% | ||
| FCFM | 11.15% |
ROA(3y)3.15%
ROA(5y)2.86%
ROE(3y)16.5%
ROE(5y)15.14%
ROIC(3y)8.24%
ROIC(5y)7.14%
ROICexc(3y)11.9%
ROICexc(5y)10.41%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.53%
ROCE(5y)9.88%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y8.3%
ROICexc growth 5Y6.21%
OM growth 3Y5%
OM growth 5Y2.94%
PM growth 3Y0.86%
PM growth 5Y2.5%
GM growth 3Y1.59%
GM growth 5Y1.22%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 3.07 | ||
| Debt/EBITDA | 1.3 | ||
| Cap/Depr | 58.17% | ||
| Cap/Sales | 3.11% | ||
| Interest Coverage | 8.8 | ||
| Cash Conversion | 97.8% | ||
| Profit Quality | 223.37% | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.61 | ||
| Altman-Z | 1.67 |
F-Score7
WACC7.62%
ROIC/WACC1.53
Cap/Depr(3y)54.76%
Cap/Depr(5y)48.08%
Cap/Sales(3y)3.16%
Cap/Sales(5y)2.94%
Profit Quality(3y)143.57%
Profit Quality(5y)182.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-22.91%
EPS 3Y10.55%
EPS 5Y5.55%
EPS Q2Q%-34.49%
EPS Next Y10.26%
EPS Next 2Y13.58%
EPS Next 3Y13.1%
EPS Next 5Y12.81%
Revenue 1Y (TTM)11.16%
Revenue growth 3Y8.32%
Revenue growth 5Y2.26%
Sales Q2Q%8.14%
Revenue Next Year9.05%
Revenue Next 2Y8.21%
Revenue Next 3Y8.12%
Revenue Next 5Y9.1%
EBIT growth 1Y17.28%
EBIT growth 3Y13.73%
EBIT growth 5Y5.27%
EBIT Next Year47.96%
EBIT Next 3Y21.02%
EBIT Next 5Y16.04%
FCF growth 1Y47.67%
FCF growth 3Y-7.33%
FCF growth 5Y8.4%
OCF growth 1Y36.71%
OCF growth 3Y-3.84%
OCF growth 5Y7.31%
THALES SA / CSF.DE FAQ
Can you provide the ChartMill fundamental rating for THALES SA?
ChartMill assigns a fundamental rating of 5 / 10 to CSF.DE.
What is the valuation status of THALES SA (CSF.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to THALES SA (CSF.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for THALES SA?
THALES SA (CSF.DE) has a profitability rating of 6 / 10.
What is the earnings growth outlook for THALES SA?
The Earnings per Share (EPS) of THALES SA (CSF.DE) is expected to grow by 10.26% in the next year.
Is the dividend of THALES SA sustainable?
The dividend rating of THALES SA (CSF.DE) is 5 / 10 and the dividend payout ratio is 71.25%.